What Aphea.Bio does

Aphea.Bio NV is a Belgian agricultural biologicals company, founded in July 2017 as a spin-off of VIB, Ghent University, and KU Leuven, headquartered at the Technologiepark bio-accelerator in Zwijnaarde (Ghent). The company discovers and develops microbial-based crop inputs — biostimulants (ACTIV by Aphea.Bio for wheat, INITIA for maize) and biocontrol products (biofungicides VALORIA for wheat and VIRTUOSA for fruit and vegetables, with bioinsecticides and bioherbicides in the pipeline) — for conventional and sustainable agriculture. Its discovery engine is the proprietary APEXbio platform, a high-throughput pipeline combining bioinformatics, microbiome mapping, microbial culturing, automated crop phenotyping, and data analysis to screen more than 100,000 microbial strains drawn from a proprietary library of 15,000+ isolates. A second platform, TRΛNSCEND (launched September 2025 under a VLAIO grant), extends discovery to bioactive compounds from Microbial Natural Products.

The company's business model is B2B and asset-light on direct sales: commercial products are distributed through exclusive channel partnerships — ACTIV is sold across multiple European countries via Syngenta Crop Protection (initial launch Poland, June 2023) and the bioinsecticide program is co-developed with Bayer Crop Science under a partnership signed in June 2026 — generating a mix of licensing/royalty, co-development milestones, and product sales. Pricing is not publicly disclosed and is set via individual B2B agreements. Operations are anchored in Belgium, with a pilot-scale production facility inaugurated in 2023, ~65 employees as of 2025, and ~€97.5M of cumulative equity funding (Series A €7.7M 2017, Series B €19.8M 2020, Series C €70M 2023 led by Innovation Industries with Bill & Melinda Gates Foundation participation). Revenue is not publicly disclosed; ACTIV is the only product in commercial distribution, while VALORIA and VIRTUOSA are pending US EPA registration.

Name

Aphea.Bio

Legal name

Aphea.Bio NV

Website

https://aphea.bio

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Aphea.Bio NV is a Belgian agricultural biologicals company developing microbial-based biostimulants and biocontrol products (biofungicides, bioinsecticides, bioherbicides) for sustainable crop protection, discovered through its proprietary APEXbio and TRΛNSCEND R&D platforms and commercialized via channel partners including Syngenta and Bayer.

Ownership category

akta.pro rank

Product category

Agricultural Biologicals

NAICS

Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Agricultural Chemicals (2870), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biostimulants & Plant Health Biologicals (Microbial/Non-microbial) (AFABAEAK)

akta.pro secondary industries

Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL), Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)

Keywords

• Biological crop protection
• Agricultural biostimulants
• Biofungicide products
• Microbial strain discovery
• Sustainable agriculture solutions

Headquarters

HQ city

Zwijnaarde

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Biostimulant Products: Revenue from sale of microbial-based biostimulant products for seed treatment. First commercial product ACTIV launched in Poland in 2023 for wheat; INITIA for maize in development with expansion plans to US and Brazil markets.
2. Biofungicide Products: Revenue from sale of biofungicide products VALORIA for wheat and VIRTUOSA for fruit and vegetables. Products pending EPA registration in US.
3. Bioinsecticide Development: Revenue potential from bioinsecticide products developed through Bayer partnership. Partnership leverages Aphea.Bio's R&D pipeline alongside Bayer's global market reach.
4. Licensing and Co-development: Strategic partnerships including Syngenta collaboration for wheat biostimulant across multiple European countries, generating licensing and co-development revenue.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Aphea.Bio develops and commercializes microbial-based biostimulant and biocontrol products for sustainable agriculture. Its commercial portfolio includes two biostimulant seed treatments (ACTIV for wheat, INITIA for maize) and two biofungicides (VALORIA for wheat, VIRTUOSA for fruit and vegetables), with additional bioinsecticide and bioherbicide candidates in the pipeline. All products are derived from the company's proprietary APEXbio R&D platform that screens naturally occurring microorganisms for crop-enhancing and crop-protecting applications.

Product overview

Aphea.Bio is a biologicals company developing and commercializing biostimulant and biocontrol products for agriculture. The product portfolio consists of two biostimulant seed treatments (ACTIV by Aphea.Bio™ for wheat and INITIA by Aphea.Bio™ for maize) and two biofungicides submitted for regulatory approval (VALORIA™ for wheat and VIRTUOSA™ for fruit and vegetables). The company also maintains a rich pipeline of bioinsecticide and bioherbicide candidates. All products are developed using the proprietary APEXbio™ R&D platform, which screens microbial strains to identify beneficial microorganisms for crop enhancement and protection.

Differentiator

Problem solved

Functional benefit

Brands

• ACTIV by Aphea.Bio: Biostimulant seed treatment for wheat providing consistent yield increase under reduced fertilization
• INITIA by Aphea.Bio
• VALORIA
• VIRTUOSA
• APEXbio

Products and services

• ACTIV by Aphea.Bio A biostimulant seed treatment for wheat based on a proprietary strain of Stenotrophomonas rhizophila. Improves nutrient uptake, enables up to 5% higher yields even with reduced fertilizer use, and enhances crop performance under stress conditions such as drought and salinity. Distributed through Syngenta Crop Protection in Europe.
• INITIA by Aphea.Bio A biostimulant designed for maize seed treatment, enhancing germination, early vigour, root biomass, and nutrient use efficiency (nitrogen and phosphorus). Demonstrated robust yield increases under both reduced and full fertilization conditions in EU field trials, with planned market expansion to US and Brazil.
• VALORIA A foliar biofungicide for wheat based on a Streptomyces strain. Offers broad-spectrum activity protecting against head blight, yellow rust, leaf blotch, and powdery mildew. Features two-year shelf life at ambient temperatures and compatibility with standard agricultural chemicals. Pending EPA registration in the US.
• VIRTUOSA A foliar biofungicide for fruit and vegetables based on a Streptomyces strain. Provides broad-spectrum protection against diseases such as grey mold and powdery mildew. Easy-to-use liquid formulation with long shelf life, suitable for Integrated Pest Management programs. Pending EPA registration in the US.

Quantifiable outcome

• 5% yield increase (250 kg/ha additional) with ACTIV biostimulant under reduced fertilization
• +4 more outcomes

Named customers2 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• BayercoreStrategic or Co-development Partner · 10 June 2026Strategic partnership with Bayer Crop Science to develop biological insecticides targeting sap-sucking insects in agriculture. Leverages Aphea.Bio's R&D pipeline alongside Bayer's global market reach and large-scale product development capacity. Initially targeting fruit crops (citrus, grapes, pome, stone) with potential expansion to vegetables and row crops (cotton, soybean). Partnership formalized at signing ceremony in Monheim on June 9, 2026.
• Syngenta Crop ProtectioncoreChannel Partner/ Reseller/ Distributor · 1 March 2023Collaboration to accelerate introduction of novel biological seed treatment solution (ΛCTIV) across multiple countries in Europe over five years, pending regulatory approval. Syngenta Polska hosted exclusive launch event on June 5, 2023 for Polish market introduction. Market introductions in additional countries prepared for 2024.
• VIB (Flemish Institute for Biotechnology)coreTechnology or Integration · 1 July 2017Aphea.Bio founded as VIB spin-off in July 2017. VIB is a life science research organization; Johan Cardoen served as managing director from 2012-2020. Willem Broekaert represents V-Bio Ventures as Board Observer.
• Ghent UniversitycoreTechnology or Integration · 1 July 2017University partner in founding spin-off from VIB. Contributed to company's scientific foundation and ongoing research capabilities.
• KU LeuvencoreTechnology or Integration · 1 July 2017University partner in founding spin-off from VIB. Contributed to company's scientific foundation.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• AgBiome: US-based agricultural biotech using a proprietary microbial strain library and high-throughput screening platform (Genesis) to discover biocontrol and biostimulant products. Closely comparable discovery engine, target customer (row crop and specialty growers), and biological crop protection focus.
• Indigo Ag: US agricultural biologicals company developing microbial seed treatments and biostimulants for major row crops. Comparable product format (seed-applied biologicals), target crops (wheat, maize), and go-to-market with ag-input retailers and partners.
• Pivot Bio: US microbial nitrogen-fixing company with Proven® seed treatment and Proven® G3 for cereals including wheat. Direct comparable on microbial seed treatment technology, row crop focus, and partnership-driven distribution model.
• Biobest Group: Belgian biocontrol company specializing in biological crop protection including bumblebee pollination, beneficial insects, and microbial products. Same HQ country (Belgium), same biological crop protection category, and overlapping high-value crop (fruit and vegetables) focus.
• Sound Agriculture: US ag biotech with bioinspired nutrient efficiency products for row crops. Comparable in microbial and biochemical product development for nutrient use efficiency, targeting similar wheat, corn, and soybean growers.
• Bioceres Crop Solutions: Argentina-based agricultural biologicals company with biostimulant and biofungicide products (e.g., Rizoderma, Trichoderma) for row crops including wheat and soybeans. Comparable biological portfolio, Latin American market overlap (Aphea.Bio plans INITIA in Brazil), and partner-distribution strategy.

Broad incumbents

• Novonesis (Novozymes): Global market leader in enzymes and microbial solutions formed by the Novozymes-Chr. Hansen merger. Comparable broad portfolio of agricultural biologicals and biocontrol, but much larger scale, broader industrial focus, and serves many end markets beyond agriculture.
• Bayer Crop Science: One of the world's largest crop protection and seed companies, currently a strategic development partner to Aphea.Bio for bioinsecticides. Overlapping capabilities in biologicals (BioAct, Serenade) alongside synthetic chemistry and seeds. Not a direct competitor in Aphea.Bio's narrow microbial niche but rapidly expanding into biologicals.
• Syngenta Crop Protection: Global ag-input giant currently a strategic distribution partner for ACTIV across Europe. Sells its own biostimulant and biological portfolio alongside conventional chemistry. Comparable broad crop protection portfolio but operates at vastly greater scale and across all input categories.

Emerging players

• Ginkgo Bioworks: US synthetic biology platform company with an agricultural biologicals arm (formerly Joyn Bio with Bayer, now Ginkgo Ag). Comparable in using high-throughput microbial engineering and screening, but operates across many end markets (pharma, food, industrial) with agriculture as one application area.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/aphea-bio
• Xx.com/ApheaBio

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds5 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aphea.Bio